Nardone Roland M
Biology Department, Catholic University of America, McCort Ward Hall, Washington, DC 20064, USA.
Cell Biol Toxicol. 2007 Nov;23(6):367-72. doi: 10.1007/s10565-007-9019-9. Epub 2007 May 24.
This "white paper" was prepared and widely disseminated in an attempt to sound an alarm about the long-term existence of a grave, unresolved and growing problem that affects a significant portion of biomedical research, namely, the use of misidentified and cross-contaminated cell cultures. The "white paper" shows how bold action could bring about a profession-wide change in practice that would prevent further erosion. Misidentification and inter- and intra-specific cross-contamination of mammalian cell cultures used in research continues as a widespread problem despite an awareness that dates back more than 45 years. Awareness of the problem has led to a good understanding of the causes of cross-contamination and appropriate preventive measures. It has also led to the application of robust methods for the authentication of cell lines. Yet the problem continues unabated. Estimates of the incidence of research papers flawed by the use of misidentified and cross-contaminated cell cultures approximate 15-20%. The gravity of the situation calls for a strategy that would deliver a remedial message of authentication to virtually all cell culture researchers and also ensure compliance with the message. At the core of the strategy proposed herein is having cell line authentication as a condition for the award of research grants and for the publication of research findings.
这份“白皮书”被编写并广泛传播,旨在对一个严重、未解决且不断加剧的问题的长期存在发出警报,该问题影响了很大一部分生物医学研究,即错误识别和交叉污染的细胞培养物的使用。“白皮书”展示了大胆的行动如何能带来全行业的实践变革,以防止进一步的损害。尽管早在45多年前就已意识到这一问题,但研究中使用的哺乳动物细胞培养物的错误识别以及种间和种内交叉污染仍是一个普遍存在的问题。对该问题的认识促使人们很好地理解了交叉污染的原因及适当的预防措施。这也促使了可靠的细胞系鉴定方法的应用。然而,问题仍未得到缓解。据估计,因使用错误识别和交叉污染的细胞培养物而存在缺陷的研究论文的发生率约为15% - 20%。这种情况的严重性需要一种策略,该策略能向几乎所有细胞培养研究人员传达关于鉴定的补救信息,并确保他们遵守这一信息。本文提出的策略的核心是将细胞系鉴定作为授予研究资助和发表研究成果的条件。